Our mission is to pioneer and transform the way we care for patients suffering from chest pain. Because chest pain may be harbinger to a life-threatening heart attack, patients with this symptom are often under undue stress, further worsening this already trying condition. Agilance aims to solve this all-too-common problem through leveraging clinical expertise and cutting-edge technologies. We believe that the systemic insufficiencies of the current standard of care stems mainly from the lack of timely access to expert medical advice and point-of-care diagnostic testing. We envision that these obstacles can now be overcome with the advent of telemedicine, artificial intelligence, quantum biology, and other break-through technologies such as portable ultrasound diagnostics and coronary CT angiography. With the confluence of these exponential developments, it is our belief that we are poised to make impactful advances in improving clinical outcomes and patient satisfaction while lowering costs and time of medical care. Ultimately, we strive to lower the incidence of heart attacks which begrudgingly remains the leading cause of death in the world.

As proof-of-concept to this new approach to chest pain evaluation, we are launching this service only in New York City, where our headquarter is located. First and foremost, our goal is to ensure that this approach is effective and safe for patients to use. Therefore, during this beta-testing period, our service is free of charge to the user (for the initial telemedicine consultation). We hope that you are inspired to help us achieve our grand mission of improving cardiovascular health in the United States by using this platform and guiding us with your feedback.